Related Experiment Video
Updated: Jan 3, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation
Riccardo M Inciardi1,2, Robert P Giugliano3, Brian Claggett1
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Insights
Left atrial dysfunction, not size, predicts cardiovascular death or heart failure hospitalization in atrial fibrillation (AF) patients. Impaired left atrial function identifies high-risk individuals for heart failure development.
Area of Science:
- Cardiology
- Echocardiography
- Atrial Fibrillation Research
Background:
- Atrial fibrillation (AF) is associated with structural and functional changes in the left atrium (LA).
- Assessing left atrial (LA) structure and function may improve cardiovascular risk stratification in patients with AF.
Purpose of the Study:
- To evaluate the association between left atrial (LA) structure and function and the risk of cardiovascular (CV) death or heart failure (HF) hospitalization in patients with AF.
Main Methods:
- Prospective echocardiographic substudy of 971 patients from the ENGAGE AF-TIMI 48 trial.
- Assessed associations between LA volume index (LAVi), LA emptying fraction (LAEF), and LA expansion index (LAEi) with CV death or HF hospitalization.
- Utilized Cox proportional hazards models for risk assessment after adjusting for confounders.
Main Results:
- Higher LAVi and lower LAEF and LAEi were associated with increased unadjusted risk for CV death or HF hospitalization.
- After adjustment, impaired LA function (lower LAEF and LAEi) independently predicted the composite outcome.
- Predictive value of LA function was consistent across subgroups defined by left ventricular ejection fraction and AF status.
Conclusions:
- Left atrial (LA) dysfunction is a significant predictor of cardiovascular death or heart failure (HF) hospitalization in patients with atrial fibrillation (AF).
- LA functional parameters are more predictive of adverse outcomes than LA size in this population.
- LA function assessment can aid in identifying AF patients at higher risk for developing HF.
Aims:
The present study aimed to assess the association between left atrial (LA) structure and function and the risk for cardiovascular (CV) death or heart failure (HF) hospitalization in a population with atrial fibrillation (AF).
Methods And Results:
In a prospective echocardiographic substudy of the Effective Anticoagulation with Factor Xa Next Generation in AF-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) study, 971 patients underwent transthoracic echocardiography. The associations between LA structure (LA volume index [LAVi]) and function (LA emptying fraction [LAEF] and LA expansion index [LAEi]) and risk for the composite endpoint of CV death or HF hospitalization, and its components, were assessed. Over a median follow-up of 2.5 years, 142 patients (14.6%) experienced CV death or HF hospitalization. Higher LAVi and lower LAEF and LAEi were each associated with a higher unadjusted risk for the composite outcome and its components. After adjustment for clinical and echocardiographic confounders, only measures of impaired LA function were predictive of the composite outcome (hazard ratio [HR] per 1 standard deviation [SD] decrease in LAEF: 1.35; 95% confidence interval [CI] 1.09-1.67 [P = 0.005]; HR per 1 SD decrease in LAEi: 1.34; 95% CI 1.06-1.69 [P = 0.012]). These findings were similar regardless of left ventricular ejection fraction, history of HF or whether patients were in AF or sinus rhythm at the time of the echocardiographic examination.
Conclusions:
In patients with AF, LA dysfunction was significantly associated with an increased risk for CV death or HF hospitalization and was more predictive of these outcomes than LA size. These parameters may help to identify AF patients at greatest risk for the development of HF.
Clinical Trial Registration:
ClinicalTrials.gov, NCT00781391.
Related Concept Videos
Chambers of the Heart
Deoxygenated blood from the body is received in the right...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Rheumatic Heart Disease I: Introduction
Overview of the Heart
The heart's structure...
Pathophysiology of Heart Failure

